| Patient | Winston Churchill |
|---|---|
| Date of birth | 1947-11-30 |
| Identifiers | MRN HR-ET001-SYN; SSN (made up) 000-01-8846 |
| Document date | 2026-10-28 |
| Author | Beatrice Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Subsequent annual wellness visit; no new complaints. [S]
Mr. Churchill returns for his subsequent annual wellness visit, three weeks after his three-month stroke review. He completed the health risk assessment before the visit. He is back at full work and gave a long speech without difficulty. He has had no falls, no further lightheadedness since amlodipine was reduced, and no new neurological symptoms. He takes his medicines from a weekly organizer. He now smokes about three cigars a day and drinks every day, less than before the stroke. [S]
| Element | Detail |
|---|---|
| Visit | Subsequent annual wellness visit |
| Since the stroke | Back at full work; no new neurological symptoms |
| Safety events | No falls since the near-fall in July |
| Medicines | Adherent with a weekly organizer; no new over-the-counter medicines |
| Active conditions | Recovering lacunar stroke, hypertension, and cigar smoking |
| Functional status | Independent in all activities of daily living; modified Rankin Scale 1 |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, and improving since the summer |
| Psychosocial | Married; large family and staff; mood good; work stress high but welcome |
| Behavioral | About three cigars a day; drinks daily, two or three drinks on most days; little planned exercise apart from walking; sleeps late and naps after lunch |
| Activities of daily living | Independent in bathing, dressing, eating, toileting, and transfers |
| Instrumental activities of daily living | Manages his medicines with an organizer; staff handle his correspondence and travel |
| Home safety | Grab bar fitted in the bathroom after the stroke; good lighting on the stairs; smoke detectors working |
| Hearing and vision | No hearing concerns; reading glasses; last eye examination more than a year ago |
| Bladder | Gets up once at night to pass urine; no leakage |
| Memory | No concerns; MoCA improved |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; good energy |
| Eyes | Negative | No visual loss or diplopia |
| Ears, nose, mouth, and throat | Negative | No hearing loss or swallowing difficulty |
| Cardiovascular | Negative | No chest pain, palpitations, or lightheadedness on standing |
| Respiratory | Negative | No cough beyond a morning clearing of the throat; no breathlessness |
| Gastrointestinal | Negative | No black stools or reflux |
| Genitourinary | Negative | Nocturia once; no hesitancy or hematuria |
| Musculoskeletal | Negative | No falls or joint pain |
| Integumentary | Negative | No new or changing skin lesions |
| Neurological | Negative | Left hand slightly less nimble when tired; no new weakness, numbness, or speech change |
| Psychiatric | Negative | Mood good; tearfulness now rare; PHQ-9 score 3 |
| Hematologic | Negative | No easy bruising or bleeding on clopidogrel |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily for 21 days with clopidogrel | One tablet by mouth daily | Oral route | 2026-06-23 to 2026-07-14 | completed | S |
| Clopidogrel 75 mg oral tablet, one tablet by mouth daily (after a 300 mg loading dose in the hospital) | One tablet by mouth daily | Oral route | 2026-06-23 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-06-23 | active | S |
| Amlodipine 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-06-26 to 2026-07-01 | completed | S |
| Amlodipine 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-07-01 to 2026-07-29 | completed | S |
| Lisinopril 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-07-15 | active | S |
| Amlodipine 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-07-29 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-28 | Body height | 168 | cm | S |
| 2026-10-28 | Body weight | 78.4 | kg | S |
| 2026-10-28 | Body mass index (BMI) [Ratio] | 27.8 | kg/m2 | S |
| 2026-10-28 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-10-28 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-10-28 | Heart rate | 68 | /min | S |
| 2026-10-28 | Respiratory rate | 16 | /min | S |
| 2026-10-28 | Body temperature | 36.6 | Cel | S |
| 2026-10-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 2026-10-28 | Total score [MoCA] | 27 | {score} | S | ||
| 2026-10-28 | Total score [AUDIT-C] | 5 | {score} | S |
Vital signs recorded on 2026-10-28; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well-appearing; weight 78.4 kg, BMI 27.8 |
| Eyes | Pupils equal and reactive; visual fields full to confrontation |
| Ears | Canals clear; whispered-voice test passed on both sides |
| Neck | No carotid bruits |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender |
| Musculoskeletal | Timed Up and Go 11 seconds without a stick; slight left circumduction when tired |
| Neurological | Speech normal; faint left pronator drift; MoCA 27 of 30 |
| Psychiatric | Euthymic, witty, and engaged |
| Skin | Seborrheic keratoses on the trunk; no suspicious lesions |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Mild left hemiparesis and dysarthria after a right-hemisphere lacunar infarct eight days before intake; synthetic modern episode linked to the documented 1953 stroke | active | confirmed | I69.354 | S — Synthetic modern diagnosis; the 1953 stroke remains D in the history. |
| Essential hypertension | active | confirmed | I10 | S — Synthetic diagnosis supported by the documented raised blood pressure after the 1953 stroke. |
| Nicotine dependence, cigars, six to eight a day | active | confirmed | F17.290 | S — Synthetic coded diagnosis echoing the documented lifelong cigar smoking. |
| Orthostatic hypotension after antihypertensive intensification in hot weather, resolved after reducing amlodipine | resolved | confirmed | I95.1 | S — Synthetic medication-related intercurrent problem at an unscheduled visit; it does not echo a documented illness. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, 2026-2027 | Completed today | High-dose vaccine given today |
| COVID-19 vaccine, 2026-2027 | Due | Recommended at his age; he will have it at his pharmacy |
| Pneumococcal vaccine | Up to date | PCV20 about four years ago; no further doses needed |
| RSV vaccine | Up to date | Single dose about two years ago |
| Recombinant zoster vaccine | Up to date | Two-dose series completed about seven years ago |
| Tetanus booster | Up to date | Tdap about eight and a half years ago; next due in about a year and a half |
| Depression screening | Completed today | PHQ-9 score 3 |
| Unhealthy alcohol use screening and counseling | Completed today | AUDIT-C score 5; brief counseling given |
| Tobacco use | Completed today | About three cigars a day; advice to stop and an offer of nicotine replacement, declined |
| Cognitive assessment | Completed today | MoCA 27 of 30 |
| Falls prevention | Completed today | No falls; Timed Up and Go 11 seconds; outpatient physical therapy completed last month |
| Cholesterol and diabetes screening | Up to date | LDL cholesterol 58 mg/dL in August; HbA1c 5.5% in July |
| Colorectal cancer screening | Not indicated | Age 78 with normal screening in the past; after discussion he declines further screening |
| Prostate cancer screening | Not indicated | Not recommended after 70 |
| Abdominal aortic aneurysm screening | Not indicated | Recommended only for men aged 65 to 75 who have smoked |
| Lung cancer screening | Not indicated | Eligibility is based on cigarette pack-years; he has smoked cigars only |
| Eye examination | Due | More than a year since his last examination; he will book with his optometrist |
Immunizations given today: High-dose influenza vaccine, 2026-2027 season [S]
Guideline basis: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026)
Follow-up: Stroke and blood pressure review in about three months with a basic metabolic panel. Next annual wellness visit in one year. [S]
Voluntary advance care planning discussion of about 20 minutes, with his consent, prompted by the stroke. He has named a health care agent and completed a written health care directive; a copy is now in the chart. He wants full treatment, including thrombolysis or thrombectomy, for another stroke from which he could return to work. He would not want prolonged tube feeding or mechanical ventilation after a severe stroke that left him unable to speak or recognize those close to him. He will review these wishes with his agent. [S]